Skip to content

Evaluation of an Ultraportable ECG Recording Device and Its Visualization Software for the Detection of Atrial Fibrillation

Evaluation of an Ultraportable ECG Recording Device and Its Visualization Software for the Detection of Atrial Fibrillation

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03975725
Acronym
WITCARD
Enrollment
400
Registered
2019-06-05
Start date
2019-09-30
Completion date
2023-03-31
Last updated
2019-06-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cardiovascular Illnesses

Brief summary

The purpose is to demonstrate the usefulness of WitCard and WitDisplayer in the diagnosis of AF but more generally in the qualification of the heart rhythm and the diagnosis of cardiac arrhythmias. The main objective is therefore to demonstrate that at least 90 +/- 0.03% of ECGWs are interpretable by a physician and the primary endpoint will therefore be the ratio of the number of ECGWs that allowed a physician to make a diagnosis. rhythmic (ECGW interpretable) and the total number of ECGW recorded and viewed. The clinical trial as part of the CE medical device certification process for secondary objectives and ancillary studies will be required to assess the diagnostic performance of the WitCard + WitDisplayer system, the quality of the ECGW recorded by the WitCard, the the safety of using the WitCard, the technical performance of the WitCard ECG recorder, the ergonomics of the WitCard, and finally the performance of automatic cardiac rhythm classification algorithms.

Detailed description

Monocentric, prospective, interventional study

Interventions

DEVICEthe use of the WitCard

electrocardiogram (ECG)

OTHERthe use of WitDisplayer

a software to visualize, measure, annotate, comment, archive, and share the different ECGs acquired with the WitCard (ECGW) of different patients.

Sponsors

Assistance Publique Hopitaux De Marseille
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
OTHER
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

Patient, male or female, over 18 years of age, presenting to the cardiology-rhythmology department (consultations and hospitalizations) or to the emergency department of the Timone 2 Hospital for the management of suspicion of disorder heart rate in front of: * Palpitations * Dyspnoea, acute pulmonary edema, non-ischemic heart failure * Malaise, lipothymia, syncope

Exclusion criteria

* Patients with clinical criteria that do not warrant the use of WitCard: * Immediate vital risk whatever its nature * Rhythmic urgency requiring treatment without delay: respiratory, circulatory or neurological distress * Acute Coronary Syndrome * Pregnant women * Non-beneficiaries of a social security scheme * Persons deprived of their liberty * Patient participating in another study * Patient in a period of exclusion determined by a previous study * Patient under the protection of justice, under guardianship or under guardianship

Design outcomes

Primary

MeasureTime frame
the ratio between the number of ECGWs that allowed a physician to make a rhythmic diagnosis (ECGW interpretable) and the total number of ECGWs recorded and visualized.9 months

Contacts

Primary Contactjean-claude deharo
JeanClaude.DEHARO@ap-hm.fr04 91 69 89 24

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026